“Ping‑pong gaze” secondary to monoamine oxidase inhibitor overdose

Attaway, Amy; Sroujieh, Laila; Mersfelder, Tracey L.; Butler, Christopher; Ouellette, Daniel

doi:10.4103/0976-500X.179360

Case ReportArchivesVol. 7 | Issue 1 | 2016 | pp. 34–37Open Access

“Ping‑pong gaze” secondary to monoamine oxidase inhibitor overdose

¹^*,
²,
³,
⁴,
⁴

¹Department of Pulmonary Critical Care, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.
²Department of Pulmonary Critical Care, MetroHealth Medical Center, Cleveland, Ohio, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.
³Department of Pharmacy, Ferris State University, Borgess Hospital, Kalamazoo, Michigan, USA.
⁴Pulmonary Critical Care, Henry Ford Health System, Detroit, USA.

Correspondence: Amy Attaway
Department of Pulmonary Critical Care, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.
Email: amy.attaway@uhhospitals.org

Published: Jan 1, 2016, Received: Jan 23, 2015, Accepted: Jun 12, 2015

DOI: https://doi.org/10.4103/0976-500X.179360
Article URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-7-1-34
PDF URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-7-1-34.pdf

Abstract

An infrequent manifestation of monoamine oxidase inhibitor (MAOI) toxicity is “ping-pong gaze” (PPG). We describe the case of a 26-year-old female who was found unresponsive after taking 40 tablets of phenelzine. On presentation to the hospital, her eyes were moving in characteristic “ping pong” fashion. After 6 hours her gaze terminated. The following day her neurologic exam was benign and she had no long-term sequelae. While the etiology of PPG is unknown, it is most often seen with irreversible structural brain damage. However, a detailed literature review revealed that previous cases of MAOI toxicity where the patient survived have all had complete neurologic recovery.

Keywords

Subject

Readers Also Viewed

Review Article

Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review

Mohammad Akbar Hossain

Jan 1, 2026

Review Article

Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions

Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei

Jan 1, 2025

Original Research Article

Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models

Annisa Fatharani, Ali Alsayegh

Jan 1, 2026